| |
| |
|
| Insider
Information: |
Quinlan Kevin W |
| Relationship: |
Chief Financial Officer |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
29,612 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$748,020 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,612 |
|
|
| Total
Value |
$748,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pressure Biosciences Inc |
PBIO |
Director |
2005-02-11 |
2,500 |
2005-02-11 |
0 |
Premium* |
|
|
Anika Therapeutics Inc |
ANIK |
Chief Financial Officer |
2013-03-27 |
27,112 |
2008-03-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-27 |
4 |
S |
$11.24 |
$206,524 |
D/D |
(18,374) |
27,112 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-27 |
4 |
A |
$11.24 |
$206,524 |
D/D |
18,374 |
45,486 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-22 |
4 |
S |
$11.24 |
$355,476 |
D/D |
(31,626) |
27,112 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-22 |
4 |
A |
$11.24 |
$355,476 |
D/D |
31,626 |
47,110 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-21 |
4 |
S |
$11.24 |
$281,000 |
D/D |
(25,000) |
27,112 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-03-21 |
4 |
A |
$11.24 |
$281,000 |
D/D |
25,000 |
52,112 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-02-27 |
4 |
OE |
$6.99 |
$79,462 |
D/D |
11,368 |
27,112 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-08-23 |
4 |
B |
$5.00 |
$20,000 |
D/D |
4,000 |
15,744 |
2.74 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,744 |
11,744 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-11-07 |
4 |
B |
$5.20 |
$5,200 |
D/D |
1,000 |
5,000 |
2.74 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-11-06 |
4 |
B |
$5.34 |
$5,340 |
D/D |
1,000 |
4,000 |
2.74 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-03-19 |
4 |
B |
$8.20 |
$16,578 |
D/D |
2,000 |
3,000 |
2.74 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-03-10 |
4 |
B |
$9.80 |
$9,875 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| PBIO |
Pressure Biosciences Inc |
Director |
– • – |
2005-02-11 |
4 |
D |
$3.50 |
$578,354 |
D/D |
(165,244) |
2,500 |
|
- |
|
| PBIO |
Pressure Biosciences Inc |
Director |
– • – |
2005-02-11 |
4 |
OE |
$2.60 |
$389,010 |
D/D |
136,000 |
167,744 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
